Executive chairperson of Bengaluru-headquartered Biocon Ltd Kiran Mazumdar-Shaw said on Monday night that she has tested positive for COVID-19. Photograph: Kind courtesy @KiranShaw/Twitter......
Hundreds of wealthy Indians, including business people, figure in the 'Pandora Papers' that has uncovered financial assets of rich individuals across the world, and many of the Indians have......
On her first visit to any state in the Indian Union after being sworn in as President of the Republic, Rashtrapati Droupadi Murmu was felicitated in Bengaluru by some of that city's luminaries.......
Sources within the Congress, including those who have been members of the teams that drafted its 2019 and 2024 Lok Sabha poll manifestos, said the Karnataka government decision lacked any empirical......
Biotechnology major Biocon on Monday said it will launch biologic drug Itolizumab for the treatment of moderate to severe COVID-19 patients at a price of around 8,000 per vial. The company......
Raising overseas debt has become prohibitively expensive due to the depreciating rupee. Photograph: Kind courtesy Jatinder Jeetu/Pixabay Indian companies' foreign borrowings plunged 20.2 per cent......
Billionaire Gautam Adani, Tata Sons chairman N Chandrasekaran and business tycoon Anil Ambani led India Inc. in paying tributes to former Prime Minister Manmohan Singh, calling him the architect of......
Even as the speculation over his exact role at Infosys continues unabated, Rohan Murty has already impressed the company’s newly-appointed independent director and Biocon chairperson, Kiran......
'It is not just the US and European opportunity, but it is a huge global opportunity.' Photograph: Kind courtesy Biocon The peptides and GLP-1 class of drugs that are offering breakthrough......
In India, itolizumab, known by the brand name Alzumab, has been priced at Rs 8,000 per vial. Most patients require four vials for Covid-19 treatment, taking the cost of the therapy to Rs 32,000.......